PetVivo
PetVivo
PETV
OTC
0.50
USD
-3.85%
About
PetVivo Holdings, Inc. is a biomedical device company focused on the manufacturing, commercialization and licensing of medical devices and therapeutics for companion animals. The Company has developed a pipeline of products for the medical treatment of animals and people, with a portfolio of 21 patents that protect the Company’s biomaterials, products, production processes and methods of use.
Spryng with OsteoCushion Technology, its flagship product, is a veterinarian-administered, intra-articular injectable designed for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses. It also has a pipeline that includes several therapeutic devices for both veterinary and human clinical applications.
The Company manufactures its products in an ISO 7 certified clean room manufacturing facility in Minneapolis using its patented and scalable self-assembly production process. The Company may establish strategic out-licensing partnerships..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 15.5K |
| Three Month Average Volume | 446.7K |
| High Low | |
| Fifty-Two Week High | 2.1901 USD |
| Fifty-Two Week Low | 0.2904 USD |
| Fifty-Two Week High Date | 11 Oct 2023 |
| Fifty-Two Week Low Date | 05 Aug 2024 |
| Price and Volume | |
| Current Price | 0.7701 USD |
| Beta | 3 |
| Relative Price Change | |
| Four Week Relative Price Change | 18.34% |
| Thirteen Week Relative Price Change | 14.21% |
| Twenty-Six Week Relative Price Change | -35.14% |
| Fifty-Two Week Relative Price Change | -69.87% |
| Year-to-Date Relative Price Change | -38.65% |
| Price Change | |
| One Day Price Change | 6.96% |
| Thirteen Week Price Change | 22.24% |
| Twenty-Six Week Price Change | -28.69% |
| Five Day Price Change | 38.51% |
| Fifty-Two Week Price Change | -62.25% |
| Year-to-Date Price Change | -27.35% |
| Month-to-Date Price Change | 20.33% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.04021 USD |
| Book Value Per Share (Most Recent Quarter) | 0.04167 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.03845 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.04027 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.61331 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.06934 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.06203 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.78422 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.67047 USD |
| Normalized (Last Fiscal Year) | -0.76077 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.78422 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.67047 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.78422 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.67047 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.00512 USD |
| Cash Per Share (Most Recent Quarter) | 0.00062 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.77514 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.63472 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.44925 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -1,031 |
| Cash Flow Revenue (Trailing Twelve Months) | -724 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -1,036.50% |
| Pretax Margin (Last Fiscal Year) | -1,130.92% |
| Pretax Margin (5 Year) | -1,501.44% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 76.34% |
| Gross Margin (Trailing Twelve Months) | 83.60% |
| Gross Margin (5 Year) | 66.21% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -1,130.25% |
| Operating Margin (Trailing Twelve Months) | -1,035.57% |
| Operating Margin (5 Year) | -1,405.08% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -1,130.92% |
| Net Profit Margin (Trailing Twelve Months) | -1,036.50% |
| Net Profit Margin (5 Year) | -1,501.44% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 5.61% |
| Revenue Growth (3 Year) | -99,999.99% |
| Revenue Change (Trailing Twelve Months) | -0.09% |
| Revenue Per Share Growth | -99,999.99% |
| Revenue Growth (5 Year) | 325.44% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 23.91% |
| Total Debt (5 Year) | 10.29% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 55.86% |
| EPS Change (Trailing Twelve Months) | 25.85% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 23 |
| Price to Tangible Book (Most Recent Quarter) | 19 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 6.3K |
| Net Debt (Last Fiscal Year) | 83.3K |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 16 |
| Price to Sales (Trailing Twelve Months) | 16 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 19 |
| Price to Book (Most Recent Quarter) | 18 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 2 |
| Long Term Debt to Equity (Most Recent Quarter) | 1 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 0 |
| Quick Ratio (Most Recent Quarter) | 0 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 1 |
| Current Ratio (Most Recent Quarter) | 1 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -7,728,690 |
| Free Cash Flow (Trailing Twelve Months) | -7,063,580 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -1,644 |
| Net Interest Coverage (Trailing Twelve Months) | -1,075 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 25 |
| Total Debt to Equity (Most Recent Quarter) | 2 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -394.49% |
| Return on Assets (Trailing Twelve Months) | -337.63% |
| Return on Assets (5 Year) | -230.77% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -1,552.86% |
| Return on Equity (Trailing Twelve Months) | -1,646.73% |
| Return on Equity (5 Year) | -644.66% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -815.08% |
| Return on Investment (Trailing Twelve Months) | -589.09% |
| Return on Investment (5 Year) | -467.99% |